Al-Sharif Eman, Alsuhaibani Adel H
Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Saudi J Ophthalmol. 2017 Jul-Sep;31(3):156-161. doi: 10.1016/j.sjopt.2017.05.017. Epub 2017 Jun 14.
Orbital decompression is an effective and invaluable procedure for addressing some of the chronic manifestations of Graves' Ophthalmopathy (GO) such as exophthalmos and orbital congestion. Fat-removal orbital decompression (FROD) started to gain popularity after its introduction in the late 20th century. Among the therapeutic armamentarium of techniques and approaches available for orbital decompression, FROD has proven its efficacy and safety in addition to its ability to reduce proptosis in a relatively predictable manner. In addition, postoperative complications occurring after FROD are generally considered to be less frequent and less serious compared to bone-removal orbital decompression (BROD). Nevertheless, despite of FROD's high benefit-to-risk ratio, proper selection of patients based on meticulous preoperative assessment, including imaging, is of paramount importance to achieve optimal functional and aesthetic results. Although up till now there is still no consensus regarding the procedure of choice in GO patients, FROD is an important option to consider in this subset of patients.
眼眶减压术是治疗Graves眼病（GO）某些慢性表现（如眼球突出和眼眶充血）的一种有效且极为重要的手术。脂肪去除性眼眶减压术（FROD）自20世纪末引入后开始受到欢迎。在眼眶减压可用的一系列治疗技术和方法中，FROD除了能够以相对可预测的方式减轻眼球突出外，还证明了其有效性和安全性。此外，与去除骨组织的眼眶减压术（BROD）相比，FROD术后并发症的发生率通常被认为更低，也没那么严重。然而，尽管FROD的效益风险比很高，但基于细致的术前评估（包括影像学检查）来正确选择患者对于实现最佳的功能和美学效果至关重要。尽管到目前为止，对于GO患者的首选手术方式仍未达成共识，但FROD是这类患者需要考虑的一个重要选择。
